Alternative protein producer Calysta announced a $30 million investment from BP Ventures to support a worldwide rollout of Calysta’s FeedKind® protein. The investment will help Calysta expand production of its sustainable single-cell protein, which is produced through a proprietary, commercially-validated gas fermentation process using naturally occurring, non-GM microbes with the unique ability to use methane as their energy source. Through extensive customer trials around the world, FeedKind protein has been demonstrated to be an effective, safe and nutritious feed ingredient.

The investment agreement will also see BP and Calysta establish a strategic partnership around gas and power supply.

FeedKind is already being produced from the company’s Market Introduction Facility (MIF) in Teesside, England to support market development activities with leading animal nutrition companies around the world.